However, although the preclinical studies cited above point toward potential metabolic effects of SDF-1, it is unknown whether there are any physiological or pharmacological consequences of DPP-4-mediated cleavage of SDF-1 for metabolic control in humans
Emerging evidence indicates their potential role in the management of diverse obesity-related comorbidities, including metabolic dysfunction-associated steatotic liver disease, obstructive sleep apnea, polycystic ovary syndrome, neurodegenerative disorders, and even substance use disorders
Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial
Packer, M
These effects make GLP-1 injections an effective option for weight loss, as they help control hunger, reduce cravings, and encourage healthier eating habits